返回排名列表

Aflac Inc (AFL)

合理估值
Financial ServicesInsurance - LifeUnited States

基本面

60

价格

$111.03

市值

$56.93B

第一部分 · 这家公司值多少

概览

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 2026年9月17日 with claude-haiku-4-5 — shared with all users

P/E: 20.4Score: 55Market cap: $14.42B

Through its Colonial Life brand, Unum sells accident, hospital indemnity, cancer and critical illness policies to employees at the workplace in the United States, the same worksite voluntary-benefits business that is Aflac U.S.

P/E: 18.0Score: 52Market cap: $60.89B

Its Group Benefits arm offers accident, critical illness and hospital indemnity cover to U.S. employers through the same brokers Aflac relies on, and it is also one of the foreign insurers selling health protection products in Japan.

P/E: 11.0Score: 79Market cap: $12.81B

Its Family Heritage and Liberty National divisions sell limited-benefit supplemental health cover, including cancer and critical illness, to middle-income American families and small-business employees.

Dai-ichi Life Holdings, Inc. (第一生命ホールディングス株式会社)Not tracked

One of Japan's largest life insurers, it sells medical and cancer cover — the "third sector" products from which Aflac draws most of its profits — to Japanese households through its own agents, bank branches and its Neo First Life arm.

Tokio Marine Holdings, Inc. (東京海上ホールディングス株式会社)Not tracked

Its life subsidiary, Tokio Marine & Nichido Life, specialises in "living protection" — medical and cancer policies for Japanese individuals — competing directly with Aflac Japan's core line.

StanCorp Financial Group, Inc. (The Standard)Not tracked

After buying Allstate's Employer Voluntary Benefits business in April 2025, this insurer distributes supplemental accident, illness and life cover to millions of U.S. employees through workplace brokers.

资产负债表与流动性

营收

$18.07B

最近12个月(截至2026/6/30)

净利润

$4.86B

最近12个月(截至2026/6/30)

自由现金流

-

股东权益合计

$29.49B

负债合计

$86.98B

流动比率

0.04

利息覆盖率

-

债务/EBITDA

2.67

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

保险合理估值

公允价值

$144.00

当前价格

$111.03

安全边际

+22.9%

公允价值区间

$107.59 - $180.41

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:$118.53
现金流折现法(DCF):不适用于此类公司
市盈率法(P/E):$143.73
格雷厄姆成长公式:不适用于此类公司
盈利能力价值(EPV):不适用于此类公司
合理市净率(P/B):$176.53
股息折现模型(戈登模型):$58.29
P/FFO(运营资金):不适用于此类公司
周期中段收益:不适用于此类公司
市销率法(P/S):不适用于此类公司
分析师共识:持有 (3B / 12H / 9S)
最近财报超预期:-1.98%

估值指标

市盈率(P/E)

12.06

ROE

12.4%

市净率(P/B)

1.85

P/FCF

-

毛利率

-

ROIC

-

盈利能力雷达图

价值创造(经济护城河)

ROIC

-

WACC

6.5%

ROIC − WACC

-

基本面分析标准

通过(12)

  • EPS shows upward trend
  • Price CAGR 12.73%
  • P/B Ratio 1.85
  • Debt/Equity ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • ROE 16.4%
  • Earnings Surprise avg 6.1%
  • Share Dilution -5.4%
  • Net Margin Trend 26.9% vs 15.3%

未通过(7)

  • EPS CAGR 4.10%
  • DCF valuation (Unknown)
  • Revenue Growth 5Y -5.0%
  • Analyst Consensus 13% Buy
  • PEG Ratio 27.31
  • Earnings Quality (OCF/NI) 0.54
  • Piotroski F-Score 4/9

不可用(9)

  • ROIC NaN%
  • Gross Margin NaN%
  • P/FCF NaN
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage

Piotroski F-评分

4/9

信号混杂:部分领域需关注

score
criteria

盈利质量

0.54

中等:利润与现金之间存在一定差距

股权稀释

-5.4%

正在回购股份,对股东友好

机构持股

公司治理

管理团队

姓名职位年龄
Mr. Daniel Paul AmosChairman & CEO73
Mr. Virgil Raynard MillerPresident56
Mr. Max Kristian Broden C.F.A.Senior EVP & CFO46
Mr. Bradley Eugene Dyslin C.F.A.Executive VP & Global Chief Investment Officer59
Ms. Audrey Boone Tillman Esq.Senior EVP, & General Counsel60
Ms. Robin Littrell Blackmon CPA, CGMASenior VP of Financial Services & Chief Accounting Officer61
Mr. David A. YoungVice President of Capital Markets-
Mr. Bradley L. KnoxSenior VP & Counsel of Federal Relations-
Mr. Steven Kent BeaverExecutive Vice President; Chief Financial Officer, Aflac Life Insurance Japan60
Mr. Timothy L. Callahan CISM, CISSP, CRISCSenior VP & Chief Information Security Officer-

审计风险

8

董事会风险

5

薪酬风险

6

股东权利风险

9

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-02-25

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-08-07

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-08-06

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for AFL, sourced from Markets Gazette.

  • 5/21/2026NEUTRAL
    Aflac Follows Alphabet Into Japan’s Booming Yen Bond Market

    Aflac Inc. has entered Japan's burgeoning yen bond market, successfully issuing ¥65.9 billion ($415 million) across four tranches. This move positions Aflac alongside other foreign entities capitalizing on Japan's credit market, which is experiencing increased activity. The issuance is a strategic financial maneuver for Aflac, aimed at diversifying funding sources and potentially leveraging favorable borrowing conditions in the Japanese market. While the issuance itself is a financial operation, its direct impact on Aflac's stock price is neutral, reflecting a standard corporate finance activity rather than a fundamental business development.

via Markets Gazette